Subcommittee on Procedures Review (SPR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 23497-23498 [2016-09268]
Download as PDF
Federal Register / Vol. 81, No. 77 / Thursday, April 21, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–09188 Filed 4–20–16; 8:45 am]
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker, MPH, DLP,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–09270 Filed 4–20–16; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Statement of Organization, Functions,
and Delegations of Authority
jstallworth on DSK7TPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
Number, (FOA) DP16–006, Health
Promotion and Disease Prevention
Research Centers: Special Interest
Project Competitive Supplements
(SIPS).
Time and Date: 11:00 a.m.–6:00 p.m.,
EDT, May 17, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)(4)
and (6), title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Health Promotion and Disease
Prevention Research Centers: Special
Interest Project Competitive
Supplements (SIPS)’’, FOA DP16–006.
Contact Person for More Information:
Brenda Colley Gilbert, Ph.D., M.S.P.H.,
Director, Extramural Research Program
Operations and Services, CDC, 4770
Buford Highway NE., Mailstop F–80,
Atlanta, Georgia 30341, Telephone:
(770) 488–6295, BJC4@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
VerDate Sep<11>2014
13:27 Apr 20, 2016
Jkt 238001
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 81 FR 5442–5444, dated
February 2, 2016) is amended to reflect
the reorganization of the Division of
Health Care Statistics, National Center
for Health Statistics, Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Insert item (2) develops a
mathematical and survey statistical
program for weighting, estimation,
variance analysis, and inference that
will be used to obtain, evaluate, analyze,
and disseminate health care statistics
data; of the functional statement for the
Technical Services Branch (CPCDE)
within the Division of Health Care
Statistics, and renumber remaining
items accordingly.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2016–09183 Filed 4–20–16; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee on Procedures Review
(SPR), Advisory Board on Radiation
and Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
23497
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 11:00 a.m.–4:30 p.m.,
EDT, May 16, 2016.
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public, but
without a public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the teleconference at the USA
toll-free, dial-in number at 1–866–659–
0537 and the pass code is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
rechartered on March 22, 2016,
pursuant to Executive Order 13708, and
will expire on September 30, 2017.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
E:\FR\FM\21APN1.SGM
21APN1
jstallworth on DSK7TPTVN1PROD with NOTICES
23498
Federal Register / Vol. 81, No. 77 / Thursday, April 21, 2016 / Notices
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. SPR
was established to aid the Advisory
Board in carrying out its duty to advise
the Secretary, HHS, on dose
reconstruction. SPR is responsible for
overseeing, tracking, and participating
in the reviews of all procedures used in
the dose reconstruction process by the
NIOSH Division of Compensation
Analysis and Support (DCAS) and its
dose reconstruction contractor (Oak
Ridge Associated Universities—ORAU).
Matters for Discussion: The agenda for
the Subcommittee meeting includes:
Discussion of procedures in the
following ORAU and DCAS technical
documents:
OCAS Technical Information Bulletin
(TIB) 0014 (‘‘Rocky Flats Internal
Dosimetry Coworker Extension’’),
ORAU OTIB 0013 (‘‘Individual Dose
Adjustment Procedures for Y–12 Dose
Reconstructions’’), ORAU OTIB 0029
(‘‘Internal Dose Reconstructions for Y–
12’’), ORAU OTIB 0039 (‘‘Internal Dose
Reconstructions for Hanford’’), ORAU
OTIB 0050 (‘‘The Use of Rocky Flats
Neutron Dose Reconstruction Project
Data in Dose Reconstructions’’), ORAU
OTIB 0060 (‘‘Internal Dose
Reconstructions’’), Program Evaluation
Report (PER) 003 (‘‘The Effects of
Adding Ingestion Intakes to Bethlehem
Steel Cases’’), PER 004 (‘‘Application of
Photofluorography at the Pinellas
Plant’’), PER 005 (‘‘Misinterpreted
Application of External Dose Factor for
Hanford Dose Reconstructions’’), PER
029 (‘‘Hanford TBD Revision’’), PER 042
(‘‘Linde Ceramic Plant TBD Revision’’),
PER 045 (‘‘Aliquippa Forge TBD
Revision’’), ORAU PROC 0042
(‘‘Incomplete Monitoring at Y–12’’),
ORAU RPRT 0044 (‘‘Analysis of
Bioassay Data with Significant Fraction
of Less-Than Results’’); and a
continuation of the comment-resolution
process for other dose reconstruction
procedures under review by the
Subcommittee. The agenda is subject to
change as priorities dictate.
Contact Person For More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton
Road, Mailstop E–20, Atlanta, Georgia
30329–4027, Telephone (513) 533–6800,
Toll Free 1(800) CDC–INFO, Email
ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
VerDate Sep<11>2014
13:27 Apr 20, 2016
Jkt 238001
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2016–09268 Filed 4–20–16; 8:45 am]
Agency Forms Undergoing Paperwork
Reduction Act Review
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns the CDC National Centers for
Excellence in Youth Violence
Prevention: Operations Research
(Implementation Science) for
Strengthening Program Implementation
through the President’s Emergency Plan
for AIDS Relief (PEPFAR), RFA–GH–16–
005, initial review.
This publication corrects a
notice that was published in the Federal
Register on March 22, 2016 Volume 81,
Number 55, pages 15307. The meeting
place should read as follows:
SUMMARY:
DATES:
Times and Dates:
9:00 a.m.–2:00 p.m., EDT, Panel A,
April 26, 2016 (Closed)
9:00 a.m.–2:00 p.m., EDT, Panel B, April
27, 2016 (Closed)
FOR FURTHER INFORMATION CONTACT:
Hylan Shoob, Scientific Review Officer,
Center for Global Health (CGH) Science
Office, CGH, CDC, 1600 Clifton Road
NE., Mailstop D–69, Atlanta, Georgia
30033, Telephone: (404) 639–4796,
HMS4@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–09269 Filed 4–20–16; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
[30Day–16–1061]
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Behavioral Risk Factor Surveillance
System (BRFSS) (OMB Control No.
0920–1061, exp. 3/31/2018)—
Revision—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP)—Centers for
Disease Control and Prevention (CDC).
E:\FR\FM\21APN1.SGM
21APN1
Agencies
[Federal Register Volume 81, Number 77 (Thursday, April 21, 2016)]
[Notices]
[Pages 23497-23498]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-09268]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee on Procedures Review (SPR), Advisory Board on
Radiation and Worker Health (ABRWH or the Advisory Board), National
Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date: 11:00 a.m.-4:30 p.m., EDT, May 16, 2016.
Place: Audio Conference Call via FTS Conferencing.
Status: Open to the public, but without a public comment period.
The public is welcome to submit written comments in advance of the
meeting, to the contact person below. Written comments received in
advance of the meeting will be included in the official record of the
meeting. The public is also welcome to listen to the meeting by joining
the teleconference at the USA toll-free, dial-in number at 1-866-659-
0537 and the pass code is 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, rechartered on March 22, 2016,
pursuant to Executive Order 13708, and will expire on September 30,
2017.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is
[[Page 23498]]
reasonable likelihood that such radiation doses may have endangered the
health of members of this class. SPR was established to aid the
Advisory Board in carrying out its duty to advise the Secretary, HHS,
on dose reconstruction. SPR is responsible for overseeing, tracking,
and participating in the reviews of all procedures used in the dose
reconstruction process by the NIOSH Division of Compensation Analysis
and Support (DCAS) and its dose reconstruction contractor (Oak Ridge
Associated Universities--ORAU).
Matters for Discussion: The agenda for the Subcommittee meeting
includes: Discussion of procedures in the following ORAU and DCAS
technical documents:
OCAS Technical Information Bulletin (TIB) 0014 (``Rocky Flats
Internal Dosimetry Coworker Extension''), ORAU OTIB 0013 (``Individual
Dose Adjustment Procedures for Y-12 Dose Reconstructions''), ORAU OTIB
0029 (``Internal Dose Reconstructions for Y-12''), ORAU OTIB 0039
(``Internal Dose Reconstructions for Hanford''), ORAU OTIB 0050 (``The
Use of Rocky Flats Neutron Dose Reconstruction Project Data in Dose
Reconstructions''), ORAU OTIB 0060 (``Internal Dose Reconstructions''),
Program Evaluation Report (PER) 003 (``The Effects of Adding Ingestion
Intakes to Bethlehem Steel Cases''), PER 004 (``Application of
Photofluorography at the Pinellas Plant''), PER 005 (``Misinterpreted
Application of External Dose Factor for Hanford Dose
Reconstructions''), PER 029 (``Hanford TBD Revision''), PER 042
(``Linde Ceramic Plant TBD Revision''), PER 045 (``Aliquippa Forge TBD
Revision''), ORAU PROC 0042 (``Incomplete Monitoring at Y-12''), ORAU
RPRT 0044 (``Analysis of Bioassay Data with Significant Fraction of
Less-Than Results''); and a continuation of the comment-resolution
process for other dose reconstruction procedures under review by the
Subcommittee. The agenda is subject to change as priorities dictate.
Contact Person For More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta,
Georgia 30329-4027, Telephone (513) 533-6800, Toll Free 1(800) CDC-
INFO, Email ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-09268 Filed 4-20-16; 8:45 am]
BILLING CODE 4163-19-P